Antioxidant BHT 264
CAS:128-37-0
Purity:99%
Contact Now
We will contact you as soon as possible
Your Location:Home >Products >Intermediates >864070-44-0

Product Details
Quality products make an important contribution to long-term revenue and profitability. Buy reliable Quality Empagliflozin 864070-44-0 raw material with Honest Price
ChEBI: A C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor u ed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, was originally discovered by Boehringer Ingelheim and codeveloped and co-marketed through research collaboration with Eli Lilly and Co. It was first approved by European Medicine Agency (EMA) in May 2014, followed by the approval of the US FDA in August 2014. SGLT2 inhibitors are anewclass of glucose-lowering agents developed for the treatment of type 2 diabetes mellitus, which have a mechanism of action that is independent of pancreatic b-cell function or the degree of insulin resistance. Consequently, SGLT2 inhibitors have the potential to be of use not only as standalone therapy but also in combination with any of the existing classes of glucose-lowering agents, including insulin. Empagliflozin selectively inhibits SGLT2, which in turn prevents glucose reabsorption by excreting excess glucose in the urine.
The CAS number of Empagliflozin is 864070-44-0.
Synonyms for Empagliflozin 864070-44-0:(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxyMethyl)-tetrahydro-2H-pyran-3,4,5-triol;Empaglifloin;Glyxambi;mpagliflozin;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol;ozin;Empag;CS-798;EmpagL;BI-10773
Empagliflozin is a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats.
Relevant articles related to Empagliflozin:
|
Article |
Source |
|
Synthetic method of empagliflozin |
- Paragraph 0039; 0041-0042; 0044, (2021/10/30) |
|
IMPROVED PROCESS FOR THE PREPARATION OF EMPAGLIFLOZIN AND ITS CRYSTALLINE POLYMORPH |
- Page/Page column 4; 9-11, (2021/12/31) |
|
Synthetic method of empagliflozin |
- Paragraph 0029-0033, (2021/07/24) |
Huaihua Yuanyanda Biotechnology Co., Ltd is a quality supplier of Empagliflozin. Our main goal is customer satisfaction. Contact us to negotiate the best price for your business on Empagliflozin 864070-44-0.